The government recently kicked off a national campaign to encourage COVID-19 survivors to donate their convalescent plasma for patients, as clinical trials are ongoing in Indonesia, despite other countries having halted their trials following undesired results. Coordinating Human Development and Culture Minister Muhadjir Effendy cited a preliminary study by Saiful Anwar Regional General Hospital (RSUD) in Malang, East Java, which found patients with severe cases who received the experimental treatment had a 100 percent rate of recovery and critical patients had an 85 percent rate of recovery. Without disclosing further details on the study, Muhadjir said "the preliminary study can be used to predict the use of convalescent plasma for COVID-19 recovery as very meaningful". But clinical trials abroad, as well as experts at home -- both involved and not involved in local ...